Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Revenue

Samil Pharmaceutical Co.,Ltd had revenue of 50.60B KRW in the quarter ending June 30, 2026, a decrease of -5.92%. This brings the company's total for the last twelve months to 207.33B, down -4.54% year-over-year. In the year 2025, Samil Pharmaceutical Co.,Ltd had annual revenue of 210.25B, down -4.30%. That makes Samil Pharmaceutical Co.,Ltd the 19,251st largest company in the world by revenue and 1,007th in South Korea.

• Revenue (ttm): 207.33B
• Revenue Growth: -4.54%
• P/S Ratio: 0.85
• Revenue / Employee: 355.62M
• Employees: 583
• Market Cap: 175.88B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 209.59B 99.7%
• Export 665.37M 0.3%

Fiscal year ended Dec 31, 2025 See the full KRX:000520 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	210.25B	-9.45B	-4.30%
Dec 31, 2024	219.70B	23.35B	11.89%
Dec 31, 2023	196.35B	16.67B	9.28%
Dec 31, 2022	179.68B	45.43B	33.84%
Dec 31, 2021	134.25B	11.25B	9.14%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error